Position
Squarepoint Ops LLC in Monopar Therapeutics
Back to the book · All holders of MNPR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$110.6K$65.30 → $54.79
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10.5K | $687K | — | — | — | 0.0% |
| Q1 2026 | 21.8K | $1.19M | $54.79 | −$110.6K | $615.5K | 0.0% |